Cholesterol-lowering effect of a red yeast rice preparation on secondary prevention of coronary events (CCSPS)
Lu Z, Kou W, Du B
Published in American Journal of Cardiology
Methodology
Randomized, double-blind, placebo-controlled secondary prevention trial of Xuezhikang (red yeast rice extract) in post-MI Chinese patients.
Key Findings
Coronary events were reduced by 45% and cardiovascular mortality by 30% over 4.5 years.
Conclusions
Red yeast rice extract reduced recurrent coronary events in post-infarction patients.
Limitations
Single-country population; product is a standardized extract, not typical retail supplements.
Supplements Studied
Xuezhikang treatment decreased the recurrence of coronary events by 45% in patients with previous myocardial infarction.
Outcomes Measured
Xuezhikang, a partially purified extract of red yeast rice, lowered LDL cholesterol and decreased recurrence of coronary events.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.